4K aunisto J , Kelloniem i K , Sutinen E , et al. R e-evaluationof diagnostic param eters is crucial for obtaining accuratedata on idiopathic pulm onary fibrosis [J] . BMCPulm M e d ,2 0 1 5 ,1 5 :92.
5W ells A U ,C o stab el U , Poletti V , et al. Challenges inIPF diagnosis, current m anagem ent and future perspectives[J]. Sarcoidosis Vase Diffuse Lung D is,2015, 32(Suppl 1) :28-35.
6B endstrup E ,M aher T M ,M anali E D ,e t al. Challengesin the classification of fibrotic IL D [J]. Sarcoidosis VaseDiffuse Lung D is, 2 01 5,32 (Suppl 1) : 4-9.
7Jacob J , H ansell D M. H R C T of fibrosing lung disease[J]. R espirology,2 0 1 5 ,2 0 (6 ) :859-872.
8Behr J , K reuter M , H oeper M M , et al. M anagem ent ofpatients w ith idiopathic pulm onary fibrosis in clinicalpractice : the IN SIG H T S-IPF reg istry [J]. E ur R espir J ,2 0 1 5 ,4 6 (1 ):186-196.
9Pezzuto G ,Claroni G , Puxeddu E , et al. Structured m ultidisciplinarydiscussion of H R C T scans for IP F /U IP diagnosismay result in indefinite o utco m es[J]. SarcoidosisV ase Diffuse Lung Dis ,2 0 1 5 ,3 2 (1 ) : 32-36.
10M oeller A , A sk K , W arburton D , et al. T he bleomycinanimal m odel: a useful tool to investigate treatm ent optionsfor idiopathic pulm onary fibrosis- [J]. Int J BiochemCell B iol,2 0 0 8 ,4 0 (3 ) : 362-382.
